Key facts
- This page summarizes James F. Polewaczyk's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 11 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 16 Feb 2024, 17:57.
James F. Polewaczyk - 14 Feb 2024 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- IDXX
- Reported as of
- 14 Feb 2024
- Net transaction value
- -$156,396
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2024, 17:57:31 UTC
- Prior SEC filing
- 08 Dec 2023
- Next SEC filing
- 07 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
James F. Polewaczyk filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 08 Dec 2023.
- Current net transaction value: -$156,396.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +126
- Change %
- +1.3%
- Price
- $0.000000
- Shares after
- 10,189
- Date
- 14 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +216
- Change %
- +2.1%
- Price
- $0.000000
- Shares after
- 10,405
- Date
- 14 Feb 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +161
- Change %
- +1.5%
- Price
- $0.000000
- Shares after
- 10,566
- Date
- 14 Feb 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +204
- Change %
- +1.9%
- Price
- $0.000000
- Shares after
- 10,770
- Date
- 14 Feb 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +220
- Change %
- +2%
- Price
- $0.000000
- Shares after
- 10,990
- Date
- 14 Feb 2024
- Ownership
- Direct
IDXX
transaction
Common Stock
Tax liability
- Transaction value
- $156,396
- Shares
- -279
- Change %
- -2.5%
- Price
- $560.56
- Shares after
- 10,711
- Date
- 14 Feb 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -126
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 126
- Exercise price
- Footnotes
- F2
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -216
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 216
- Exercise price
- Footnotes
- F3
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -161
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 160
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 161
- Exercise price
- Footnotes
- F4
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -204
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 408
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 204
- Exercise price
- Footnotes
- F5
IDXX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -220
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 660
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 220
- Exercise price
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
Includes 13.2470 shares purchased under the Issuer Employee Stock Purchase Plan on December 29, 2023.
Footnote F2
Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2020.
Footnote F3
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning February 14, 2021.
Footnote F4
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
Footnote F5
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
Footnote F6
Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.